Keywords: javelin, dyloject, added, uk, hospital, formulary, usa-based

Javelin's Dyloject added to UK hospital formulary

Article | 24 December 2007

Print This

USA-based Javelin Pharmaceuticals announced at its New York analyst and investor day that the UK approval of Dyloject (its proprietary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in